Evaluation Of Value Creation Capacity In F Pharma Based On Balanced Scorecard

With economic boom and continuous improvement of people's living standards in the new era,the government's requirements for construction of medical security system and quality of medical products and services are getting strict dramatically.Meanwhile,people's medical concept and medical security awareness are stronger than before.Therefore,the development of the medical industry is ushering in greater opportunities and challenges.Under such condition,how pharmaceutical companies can optimize their internal processes,upgrade their industries,increase technology research and development,gain more economic benefits,and improve their overall value creation capabilities are the key for competing.This paper takes F Pharmaceutical Company as an example,one of the top ten of China Pharmaceutical groups,to analyze its internal structure and the ability to build core competitiveness,and to analyze how it protects rights and interests of internal and external stakeholders for achieving enterprise value growth and strategic development goals,and improves overall social value.The paper is divided into six chapters.The first chapter proposes the research background of the pharmaceutical industry development,and explains the research methods,ideas and technical routes,and innovative points are also illustrated.The second chapter summarizes related literature and theories.The balanced scorecard model and three processes of value creation and their usages are introduced.The third chapter makes a descriptive analysis of the macro environment and industrial competition environment where F pharmaceutical company is developing,and then introduces the company's development profile,development process,organizational structure and business module.The fourth chapter adopts the balanced scorecard model to describe and analyze F pharmaceutical company in various fields and aspects from four perspectives of finance,customers,internal processes,innovation and learning.The fifth chapter summarizes the overall structure of F pharmaceutical company,sums up the value chain guarantee and organizational structure guarantee system of value creation,and establishes the enterprise value creation evaluation model.Combined with the analysis results of the fourth chapter,this paper evaluates the ability of F pharmaceutical company in the physical processes,engineering processes and sociological processes of value creation.According to the results of the evaluation and analysis,the problems and deficiencies in the actual operation of the enterprise are summarized.The sixth chapter,based on the problems summarized in the previous chapters,solutions and suggestions are put forward,and enlightenment of this research's results are explained to highlight the main idea of this paper.As F Pharmaceutical company is a representative enterprise in the development of China's pharmaceutical industry,its business module covers the whole medical and health industry chain.As a private enterprise,F Pharmaceutical company has contributed to the development of China's pharmaceutical industry,overall economic growth and human society.As a profit-making enterprise,this paper takes it as the research object to analyze the economic value created by it,but also to focus on creating and realizing its social value.It also analyses the problems and shortcomings in the business operation process,and puts forward countermeasures and suggestions.It can be used for learning and reference for other enterprises engaging in the same industry.At the same time,it reveals the value orientation of Chinese enterprises,which should not stay in economic profits and shareholders' rights and interests,but should also raise the value creation of enterprises to a higher level and contribute to the social development.